Title: Tamie Jo Chilcote: Innovator in Plasma Kallikrein Inhibition
Introduction
Tamie Jo Chilcote is a notable inventor based in the United States. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit plasma kallikrein. Her work is essential in addressing conditions related to thrombin formation.
Latest Patents
Tamie Jo Chilcote holds a patent titled "Inhibitors Of Plasma Kallikrein." This invention provides compounds that inhibit the activity of plasma kallikrein (PK) and outlines methods for preventing and treating thrombin formation during or after a PK-dependent disease or condition, such as following fibrinolysis treatment. Although she currently has 0 patents, her research is impactful in the medical community.
Career Highlights
Chilcote is associated with Activesite Pharmaceuticals, Inc., where she applies her expertise in pharmaceutical innovation. Her role at the company allows her to contribute to the advancement of medical treatments and therapies.
Collaborations
Tamie Jo Chilcote collaborates with Sukanto Sinha, who is also a key figure in her research endeavors. Their partnership enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
Tamie Jo Chilcote is a dedicated inventor whose work in plasma kallikrein inhibition is paving the way for new therapeutic approaches. Her contributions to Activesite Pharmaceuticals, Inc. and collaboration with fellow researchers highlight her commitment to advancing medical science.